Results
1 -
10 of
24Clegg N. J., Wongvipat J., Joseph J. D., Tran C., Ouk S., Dilhas A., Chen Y., Grillot K., Bischoff E. D., Cai L., Aparicio A., Dorow S., Arora V., Shao G., Qian J., Zhao H., Yang G., Cao C., Sensintaffar J., Wasielewska T., Herbert M. R., Bonnefous C., Darimont B., Scher H. I., Smith-Jones P., Klang M., Smith N. D., De Stanchina E., Wu N., Ouerfelli O., Rix P. J., Heyman R. A., Jung M. E., Sawyers C. L., Hager J. H..
ARN-509: A Novel Antiandrogen for Prostate Cancer Treatment, Cancer Research, 2012 The Androgen Receptor as a Therapeutic Target for Castration-Resistant Prostate Cancer, Management of Castration Resistant Prostate Cancer New Frontiers in Treatment, Bone Metastases from Prostate Cancer Molecular Mechanisms of Prostate Cancer Progression After Castration, Management of Castration Resistant Prostate Cancer Molecular Targeted Therapies of Prostate Cancer, Precision Molecular Pathology of Prostate Cancer Androgen Receptor Biology in Castration Resistant Prostate Cancer, Management of Castration Resistant Prostate Cancer Targeted Therapies and Immunotherapy in Prostate Cancer, Principles and Practice of Urooncology